Skip to content
healthcare.dev

Bismuthum Oxydatum

NDC 63545-484, Bismuthum Oxydatum, pellet, from Hahnemann Laboratories, INC..

Product NDC
63545-484
Status
Listed
Labeler
Hahnemann Laboratories, INC.
Dosage form
PELLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63545-484 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BISMUTH OXIDE12 [hp_C]/1

Pharmacologic classes

Bismuth [CS]; Bismuth [EPC]

Package NDCNDC-11Package
63545-484-0163545048401200 PELLET in 1 VIAL, GLASS (63545-484-01)
63545-484-02635450484021200 PELLET in 1 BOTTLE, GLASS (63545-484-02)
63545-484-03635450484034000 PELLET in 1 BOTTLE, GLASS (63545-484-03)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63545-484 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63545-484 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63545-484. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.